Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1/2
This trial is looking at a new drug called LON002 to treat solid tumours. It is for people who have and who have no standard treatment options available to them.
Recruitment start: 1 October 2014
Recruitment end: 1 October 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Debashis Sarker
Experimental Cancer Medicine Centre (ECMC)
LondonPharma
Last reviewed: 12 October 2015
CRUK internal database number: 12745